Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 2000+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 100 Million+ Visitors
  • 75000+ Unique visitors per conference
  • 100000+ Page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Cancer Congress 2020

Welcome message

Dear Colleagues,

Conference Series extends its welcome to the conference World Cancer, Oncology and Therapeutics Congress during June 22-23, 2020 Paris, France with a theme “Empowering the Modern Research Incline to Conquer Cancer”. Conference Series LLC Ltd Organizes 1000+ Conferences Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board members. Cancer Congress 2020, Conference will focus on educational research directed toward its impact on clinical outcomes, through oral and poster presentations, educational workshop sessions, and influential plenary presentations. Cancer Congress 2020 is a perfect platform to find out how cancer and Oncology research innovations helpful to the Medical, Health and human society. Conference will mainly focus on the trending topics during presentations of the two-day event, which reflect current education, research, developments and innovations internationally in the field of cancer, oncology and medical sectors.

 

About Conference


The Conference Cancer Congress 2020

We are happy to welcome you to the official website of World Cancer, Oncology and Therapeutics Congress (Cancer Congress 2020) during June 22-23, 2020 Paris, France with the theme of “Empowering the Modern Research Incline to Conquer Cancer” which covers wide range of critically important sessions. It’s a platform to bring all the oncologists and Cancer specialists together to share their experiences it’s the amalgam of scientific research as well as innovative ideas. This includes prompt Keynote Presentations, Oral Talks, Poster Presentations, Video Presentations and Exhibitions.

Overview of Oncology and Cancer:

The Innovative idea of Cancer has started a great many research to be embraced by the labs around the world. With such an extraordinary number of researchers and scientists taking a shot at Caner research, till date, no significant solution for this is recorded. Global Cancer at Tokyo will manage Cancer Prevention, Diagnosis, and Treatment of illnesses of the Organ-related Cancers and its inventive strategies. Global Cancer will also supply the two days of discussions on methods and systems identified with administration and satisfactory exchange of Cancer and in addition to check out the new thoughts and ideas on worldwide scale and the themes include lung malignancy, bosom disease, bone tumor, leukemia, blood cancer, cervical tumor, colon-rectum disease, pediatric malignancy, surgical tumor, Prostate growth, thyroid malignancy.

Global market is segmented into Europe, North America, Latin America, Asia pacific, and Middle East and Africa. According to market study, Market Value for Oncology will be more than double to $ 623 Million by 2020. A major part of research is going on the top Universities on across the globe. Many companies are associated with various Cancer Screening and Diagnostics instruments and other therapeutics. Besides this various societies, associations and research center are also associated in this research field.

Cancer is the second driving reason for death in the US. This year around 764,800 Americans are expected cancer deaths more than 1,900 individuals in a day. One of each four death’s in the US is from growth. Since 1990, approximately there have been 5 million deaths. Lung Cancer, Blood Cancer, Breast Cancer are most common Cancers in Japan.

As per 2012 insights around 14.1 million cases are passed on and 8.2 million deaths are accounted for. Lung, Brain, Stomach and bowel malignancies cause the most widely recognized deaths among the worldwide that records almost 60% of all the cancer deaths. In males 5 most regular sites of malignancy are recognized in 2014 were lung, prostate, colorectal and liver diseases. In females 5 most shared locales analyzed were bosom, Ovary and stomach tumor.

Target Audience:

  • Cancer Institutes (Professors, Associate Professors, Professionals, Lecturers, Scientists and students, Postdoctoral fellows and Trainees)
  • Cancer Pharmaceutical Companies
  • Research scholars
  • Pathologist
  • Diagnostics companies
  • Medical Practitioners
  • Industrial Researchers
  • Academicians
  • Directors, Head of Department
  • Chemotherapists
  • Research and Development Department.
  • Business Delegates
  • Medical Colleges
  • Rehabilitation Specialists
  • Genetic scientists
  • Cancer Associations
  • Diagnostic Laboratory Professionals
  • Hospital presidents/CEOs/COOs/VPs/trustees
  • Hospital c-suite executives (operations, development, finance)
  • Oncology specialists (medical, radiation, and surgical)
  • Oncology program and practice administrators, managers, and service line executives
  • Healthcare consultants, vendors, and suppliers
  • Cancer program marketing and public relations professionals
  • Exhibitors and people with keen interest in the research areas of Cancer Research.

Who should sponsor/exhibit:

  • Basic and Translational Laboratory Researchers       
  • Hospitals
  • Educational Institutes
  • Research Centers
  • Charitable Foundations focused on funding research, advocating for and supporting the needs

Why to attend?

Oncology and Cancer will enlighten the audience with the most recent advancements in Cancer diagnosis, Cancer Science, Cancer therapy, Cancer treatment etc., around the world and to glow the related research ideas regarding Cancer Research & Oncology. Geographically people from around the world focused on getting some answers concerning Oncology and Cancer; this is your most obvious opportunity to accomplish the greatest cluster of individuals from the Cancer people group, Oncology Societies, Associations, and European Oncology Conferences. Coordinate presentations, disperse information, meet with present and potential specialists, make a sprinkle with new pharmaceutical progressions, and get name affirmation at this two days event.

The aim of the Conference is to provide a platform to academicians and practitioners from multiple disciplines to debate and deliberate on social change that is encompassed by innovation and technology.

For more details please visit: https://cancer-oncology.cancersummit.org/

Benefits of Attending the Conference:

  • Networking Opportunities, Grow Your Professional Network
  • Build Your Knowledge Base
  • Expand Your Resources
  • Meet Experts & Influencers Face to Face
  • Learning in a New Space
  • Break Out of Your Comfort Zone
  • New Tips & Tactics
  • Top Industries Representation
  • Abstracts will be published in the conference souvenir and respective International journals
  • Each Abstract will receive unique (DOI) Number provided by Cross Ref
  • Website visibility to more than 35K visitors in less than 6 months
  • Laudable talks by the top-notch of the Global Scientific Community
  • The Serendipity of the Random Workshop
  • Will be felicitated with International Organizing Committee Member (IOCM)
  • Remarkable Awards and Global Recognition to meritorious Researchers

To Collaborate Scientific Professionals around the World

Conference Date June 22-23 2020

For Sponsors & Exhibitors

[email protected]

Speaker Opportunity

Past Conference Report

Supported By

Journal of Oncology Research and Treatment Journal of Integrative Oncology Journal of Cancer Science & Therapy

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by


Past Affiliations

Speaker Logos
Speaker Logos